Robert Hershberg Hille Vax, Inc. (HLVX) insider trading activity

Robert Hershberg is President and CEO of HilleVax, Inc.. Currently has a direct ownership of 0 shares of HLVX, which is worth approximately $0. The most recent transaction as insider was on Sep 17, 2025, when has been sold 1,101,498 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

ROBERT HERSHBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 17 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	1,101,498 Reduced 100.0%	0 Common Stock
Feb 11 2025	SELL Open market or private sale	$20,945 $1.76 p/Share	11,901 Reduced 1.07%	1,101,498 Common Stock
Feb 04 2025	SELL Open market or private sale	$27,658 $1.89 p/Share	14,634 Reduced 1.3%	1,113,399 Common Stock
Feb 08 2024	SELL Open market or private sale	$173,143 $14.93 p/Share	11,597 Reduced 1.2%	953,831 Common Stock
Feb 08 2024	BUY Grant, award, or other acquisition	-	174,202 Added 13.38%	1,128,033 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	187,966 Added 16.3%	965,428 Common Stock

Also insider at

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

NSTG

NanoString Technologies Inc Healthcare

Director

SBTX

Silverback Therapeutics, Inc. Healthcare

Director

RXRX

RECURSION PHARMACEUTICALS, INC. Healthcare

Director

FATE

FATE THERAPEUTICS INC Healthcare

Director